A knowledge resource selected by UNICEF for humanitarian practitioners everywhere
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
This interim guidance has been developed based on the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its 5 January 2021 extraordinary meeting.
This document details recommended schedule to administer Pfizer–BioNTech COVID-19 vaccine doses, it details interchangeability with other vaccines, precautions, considerations for deferring the second dose, indications for the vaccination of specific population (e.g. older people) etc.